Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 RNA Interference
1.2.3 Antisense RNA
1.3 Market by Application
1.3.1 Global Antisense and RNAi Therapeutics Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense and RNAi Therapeutics Market Perspective (2018-2034)
2.2 Antisense and RNAi Therapeutics Growth Trends by Region
2.2.1 Global Antisense and RNAi Therapeutics Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Antisense and RNAi Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Antisense and RNAi Therapeutics Forecasted Market Size by Region (2024-2034)
2.3 Antisense and RNAi Therapeutics Market Dynamics
2.3.1 Antisense and RNAi Therapeutics Industry Trends
2.3.2 Antisense and RNAi Therapeutics Market Drivers
2.3.3 Antisense and RNAi Therapeutics Market Challenges
2.3.4 Antisense and RNAi Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense and RNAi Therapeutics Players by Revenue
3.1.1 Global Top Antisense and RNAi Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Antisense and RNAi Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense and RNAi Therapeutics Revenue
3.4 Global Antisense and RNAi Therapeutics Market Concentration Ratio
3.4.1 Global Antisense and RNAi Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense and RNAi Therapeutics Revenue in 2024
3.5 Antisense and RNAi Therapeutics Key Players Head office and Area Served
3.6 Key Players Antisense and RNAi Therapeutics Product Solution and Service
3.7 Date of Enter into Antisense and RNAi Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense and RNAi Therapeutics Breakdown Data by Type
4.1 Global Antisense and RNAi Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2024-2034)
5 Antisense and RNAi Therapeutics Breakdown Data by Application
5.1 Global Antisense and RNAi Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Antisense and RNAi Therapeutics Market Size (2018-2034)
6.2 North America Antisense and RNAi Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Antisense and RNAi Therapeutics Market Size by Country (2018-2023)
6.4 North America Antisense and RNAi Therapeutics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense and RNAi Therapeutics Market Size (2018-2034)
7.2 Europe Antisense and RNAi Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Antisense and RNAi Therapeutics Market Size by Country (2018-2023)
7.4 Europe Antisense and RNAi Therapeutics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense and RNAi Therapeutics Market Size (2018-2034)
8.2 Asia-Pacific Antisense and RNAi Therapeutics Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense and RNAi Therapeutics Market Size (2018-2034)
9.2 Latin America Antisense and RNAi Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Antisense and RNAi Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Antisense and RNAi Therapeutics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense and RNAi Therapeutics Market Size (2018-2034)
10.2 Middle East & Africa Antisense and RNAi Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Tekmira Pharmaceuticals
11.1.1 Tekmira Pharmaceuticals Company Detail
11.1.2 Tekmira Pharmaceuticals Business Overview
11.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.1.4 Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.1.5 Tekmira Pharmaceuticals Recent Development
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Detail
11.2.2 Arbutus Biopharma Business Overview
11.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Introduction
11.2.4 Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.2.5 Arbutus Biopharma Recent Development
11.3 Alnylam Pharmaceuticals
11.3.1 Alnylam Pharmaceuticals Company Detail
11.3.2 Alnylam Pharmaceuticals Business Overview
11.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.3.4 Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.3.5 Alnylam Pharmaceuticals Recent Development
11.4 Antisense Therapeutics
11.4.1 Antisense Therapeutics Company Detail
11.4.2 Antisense Therapeutics Business Overview
11.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Introduction
11.4.4 Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.4.5 Antisense Therapeutics Recent Development
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Company Detail
11.5.2 Silence Therapeutics Business Overview
11.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Introduction
11.5.4 Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.5.5 Silence Therapeutics Recent Development
11.6 Isis Pharmaceuticals
11.6.1 Isis Pharmaceuticals Company Detail
11.6.2 Isis Pharmaceuticals Business Overview
11.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Introduction
11.6.4 Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.6.5 Isis Pharmaceuticals Recent Development
11.7 Sirnaomics
11.7.1 Sirnaomics Company Detail
11.7.2 Sirnaomics Business Overview
11.7.3 Sirnaomics Antisense and RNAi Therapeutics Introduction
11.7.4 Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.7.5 Sirnaomics Recent Development
11.8 Santaris
11.8.1 Santaris Company Detail
11.8.2 Santaris Business Overview
11.8.3 Santaris Antisense and RNAi Therapeutics Introduction
11.8.4 Santaris Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.8.5 Santaris Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche Antisense and RNAi Therapeutics Introduction
11.9.4 Roche Revenue in Antisense and RNAi Therapeutics Business (2018-2023)
11.9.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antisense and RNAi Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of RNA Interference
Table 3. Key Players of Antisense RNA
Table 4. Global Antisense and RNAi Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Antisense and RNAi Therapeutics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Antisense and RNAi Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Antisense and RNAi Therapeutics Market Share by Region (2018-2023)
Table 8. Global Antisense and RNAi Therapeutics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Antisense and RNAi Therapeutics Market Share by Region (2024-2034)
Table 10. Antisense and RNAi Therapeutics Market Trends
Table 11. Antisense and RNAi Therapeutics Market Drivers
Table 12. Antisense and RNAi Therapeutics Market Challenges
Table 13. Antisense and RNAi Therapeutics Market Restraints
Table 14. Global Antisense and RNAi Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Antisense and RNAi Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Antisense and RNAi Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics as of 2024)
Table 17. Ranking of Global Top Antisense and RNAi Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antisense and RNAi Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antisense and RNAi Therapeutics Product Solution and Service
Table 21. Date of Enter into Antisense and RNAi Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense and RNAi Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Antisense and RNAi Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Antisense and RNAi Therapeutics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Antisense and RNAi Therapeutics Revenue Market Share by Type (2024-2034)
Table 27. Global Antisense and RNAi Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Antisense and RNAi Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Antisense and RNAi Therapeutics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Antisense and RNAi Therapeutics Revenue Market Share by Application (2024-2034)
Table 31. North America Antisense and RNAi Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Antisense and RNAi Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Antisense and RNAi Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Antisense and RNAi Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Antisense and RNAi Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Antisense and RNAi Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Antisense and RNAi Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Antisense and RNAi Therapeutics Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Antisense and RNAi Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Antisense and RNAi Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Antisense and RNAi Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Antisense and RNAi Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Antisense and RNAi Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 46. Tekmira Pharmaceuticals Company Detail
Table 47. Tekmira Pharmaceuticals Business Overview
Table 48. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 49. Tekmira Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Tekmira Pharmaceuticals Recent Development
Table 51. Arbutus Biopharma Company Detail
Table 52. Arbutus Biopharma Business Overview
Table 53. Arbutus Biopharma Antisense and RNAi Therapeutics Product
Table 54. Arbutus Biopharma Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Arbutus Biopharma Recent Development
Table 56. Alnylam Pharmaceuticals Company Detail
Table 57. Alnylam Pharmaceuticals Business Overview
Table 58. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 59. Alnylam Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Alnylam Pharmaceuticals Recent Development
Table 61. Antisense Therapeutics Company Detail
Table 62. Antisense Therapeutics Business Overview
Table 63. Antisense Therapeutics Antisense and RNAi Therapeutics Product
Table 64. Antisense Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Antisense Therapeutics Recent Development
Table 66. Silence Therapeutics Company Detail
Table 67. Silence Therapeutics Business Overview
Table 68. Silence Therapeutics Antisense and RNAi Therapeutics Product
Table 69. Silence Therapeutics Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Silence Therapeutics Recent Development
Table 71. Isis Pharmaceuticals Company Detail
Table 72. Isis Pharmaceuticals Business Overview
Table 73. Isis Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 74. Isis Pharmaceuticals Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Isis Pharmaceuticals Recent Development
Table 76. Sirnaomics Company Detail
Table 77. Sirnaomics Business Overview
Table 78. Sirnaomics Antisense and RNAi Therapeutics Product
Table 79. Sirnaomics Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Sirnaomics Recent Development
Table 81. Santaris Company Detail
Table 82. Santaris Business Overview
Table 83. Santaris Antisense and RNAi Therapeutics Product
Table 84. Santaris Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Santaris Recent Development
Table 86. Roche Company Detail
Table 87. Roche Business Overview
Table 88. Roche Antisense and RNAi Therapeutics Product
Table 89. Roche Revenue in Antisense and RNAi Therapeutics Business (2018-2023) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense and RNAi Therapeutics Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Antisense and RNAi Therapeutics Market Share by Type: 2024 VS 2034
Figure 3. RNA Interference Features
Figure 4. Antisense RNA Features
Figure 5. Global Antisense and RNAi Therapeutics Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Antisense and RNAi Therapeutics Market Share by Application: 2024 VS 2034
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Antisense and RNAi Therapeutics Report Years Considered
Figure 10. Global Antisense and RNAi Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 11. Global Antisense and RNAi Therapeutics Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Antisense and RNAi Therapeutics Market Share by Region: 2024 VS 2034
Figure 13. Global Antisense and RNAi Therapeutics Market Share by Players in 2024
Figure 14. Global Top Antisense and RNAi Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense and RNAi Therapeutics as of 2024)
Figure 15. The Top 10 and 5 Players Market Share by Antisense and RNAi Therapeutics Revenue in 2024
Figure 16. North America Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 17. North America Antisense and RNAi Therapeutics Market Share by Country (2018-2034)
Figure 18. United States Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. Canada Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Europe Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Antisense and RNAi Therapeutics Market Share by Country (2018-2034)
Figure 22. Germany Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. France Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. U.K. Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Italy Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Russia Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Nordic Countries Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Asia-Pacific Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Antisense and RNAi Therapeutics Market Share by Region (2018-2034)
Figure 30. China Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Japan Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. South Korea Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Southeast Asia Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. India Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Australia Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Latin America Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Antisense and RNAi Therapeutics Market Share by Country (2018-2034)
Figure 38. Mexico Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Brazil Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Middle East & Africa Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Antisense and RNAi Therapeutics Market Share by Country (2018-2034)
Figure 42. Turkey Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Saudi Arabia Antisense and RNAi Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Tekmira Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 45. Arbutus Biopharma Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 46. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 47. Antisense Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 48. Silence Therapeutics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 49. Isis Pharmaceuticals Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 50. Sirnaomics Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 51. Santaris Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Antisense and RNAi Therapeutics Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed